|
English
|
正體中文
|
简体中文
|
總筆數 :2853469
|
|
造訪人次 :
45152056
線上人數 :
756
教育部委託研究計畫 計畫執行:國立臺灣大學圖書館
|
|
|
"szu min hsieh"的相關文件
顯示項目 11-20 / 288 (共29頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2021-08-20T07:38:57Z |
Safety and immunogenicity of a Recombinant Stabilized Prefusion SARS-CoV-2 Spike Protein Vaccine (MVC[sbnd]COV1901) Adjuvanted with CpG 1018 and Aluminum Hydroxide in healthy adults: A Phase 1, dose-escalation study
|
SZU-MIN HSIEH; Liu W.-D.; Huang Y.-S.; Lin Y.-J.; Hsieh E.-F.; Lian W.-C.; Chen C.; Janssen R.; Shih S.-R.; Huang C.-G.; Tai I.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-20T07:38:57Z |
Healthcare-associated carbapenem-resistant Klebsiella pneumoniae bloodstream infections: Risk factors, mortality, and antimicrobial susceptibility, 2017–2019
|
Hsu J.-Y.; Chuang Y.-C.; Wang J.-T.; Chen Y.-C.; SZU-MIN HSIEH |
| 臺大學術典藏 |
2021-08-20T07:38:57Z |
Participation in cancer screening among people living with HIV at a university hospital
|
Wu P.-Y.; Sun H.-Y.; Chen M.-Y.; Sheng W.-H.; SZU-MIN HSIEH; Chuang Y.-C.; Chang H.-Y.; Luo Y.-Z.; Zhang J.-Y.; Hung C.-C. |
| 臺大學術典藏 |
2021-08-20T07:38:56Z |
A cross-sectional seroprevalence for COVID-19 among healthcare workers in a tertially care hospital in Taiwan
|
Pan S.-C.; Huang Y.-S.; SZU-MIN HSIEH; Chen Y.-C.; Chang S.-Y.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-20T07:38:56Z |
Dose-related aberrant inhibition of intracellular perforin expression by s1 subunit of spike glycoprotein that contains receptor-binding domain from sars-cov-2
|
Huang C.-F.; SZU-MIN HSIEH; Pan S.-C.; Huang Y.-S.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-20T07:38:56Z |
Evolution of estimated glomerular filtration rate in human immunodeficiency virus and hepatitis C virus-coinfected patients receiving sofosbuvir-based direct-acting antivirals and antiretroviral therapy
|
Liu C.-H.; Sun H.-Y.; SZU-MIN HSIEH; Liu W.-C.; Sheng W.-H.; Liu C.-J.; Su T.-H.; Tseng T.-C.; Chen P.-J.; Hung C.-C.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-15T05:31:49Z |
Safety and immunogenicity of a Recombinant Stabilized Prefusion SARS-CoV-2 Spike Protein Vaccine (MVC[sbnd]COV1901) Adjuvanted with CpG 1018 and Aluminum Hydroxide in healthy adults: A Phase 1, dose-escalation study
|
SZU-MIN HSIEH; Liu, Wang Da; Huang, Yu Shan; Lin, Yi Jiun; Hsieh, Erh Fang; Lian, Wei Cheng; Chen, Charles; Janssen, Robert; Shih, Shin Ru; Huang, Chung Guei; Tai, I. Chen; SHAN-CHWEN CHANG |
| 臺大學術典藏 |
2021-07-15T05:31:49Z |
Participation in cancer screening among people living with HIV at a university hospital
|
Wu, Pei Ying; HSIN-YUN SUN; Chen, Mao Yuan; WANG-HUEI SHENG; SZU-MIN HSIEH; YU-CHUNG CHUANG; Chang, Hsi Yen; Luo, Yu Zhen; Zhang, Jun Yu; CHIEN-CHING HUNG |
| 臺大學術典藏 |
2021-07-15T05:31:48Z |
Dose-related aberrant inhibition of intracellular perforin expression by s1 subunit of spike glycoprotein that contains receptor-binding domain from sars-cov-2
|
Huang, Chun Fu; SZU-MIN HSIEH; SUNG-CHING PAN; Huang, Yu Shang; SHAN-CHWEN CHANG |
| 臺大學術典藏 |
2021-07-15T05:31:43Z |
Healthcare-associated carbapenem-resistant Klebsiella pneumoniae bloodstream infections: Risk factors, mortality, and antimicrobial susceptibility, 2017–2019
|
Hsu, Jen Yu; YU-CHUNG CHUANG; JANN-TAY WANG; YEE-CHUN CHEN; SZU-MIN HSIEH |
顯示項目 11-20 / 288 (共29頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
|
